The influence of mannose-binding lectin (MBL) on the course of disease in patients with cystic fibrosis (CF).

The influence of mannose-binding lectin (MBL) on the course of disease in patients with cystic fibrosis (CF). - MBL in CF patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29945

Enrollment

170

Registered

2006-10-13

Start date

2006-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mannose-binding lectin deficiency / deficit of a protein of the immune system

Interventions

None listed

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with cystic fibrosis

Exclusion criteria

Exclusion criteria: inability/unwillingness to donate blood

Design outcomes

Primary

Measure	Time frame
1. Frequency and severity of infection 2. Lung transplantation	—

Secondary

Measure	Time frame
Secondary endpoints 1. Severity CF 2. Phagocytosis of micro-organisms, specific for CF	—

Countries

Netherlands

Outcome results